procyanidin has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, WC; Chen, CY; Chen, HF; Chen, Y; Hsueh, PR; Huang, HY; Hung, MC; Peng, SL; Shen, WJ; Wang, SC; Wang, WJ; Wu, CS | 1 |
| Bhasuran, B; Kolandaivel, P; Maroli, N; Natarajan, J | 1 |
2 other study(ies) available for procyanidin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2.
Topics: Antioxidants; COVID-19; Humans; Proanthocyanidins; SARS-CoV-2; Tannins | 2023 |
The potential role of procyanidin as a therapeutic agent against SARS-CoV-2: a text mining, molecular docking and molecular dynamics simulation approach.
Topics: COVID-19; Data Mining; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Proanthocyanidins; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |